Your browser doesn't support javascript.
loading
Effect of Infliximab and Adalimumab on Experimental Colitis Following Orally Supplemented Iron.
Triantafillidis, John; Vagianos, Costas; Agrogiannis, George; Gikas, Aristofanis; Douvi, Georgia; Syrmos, Nikolaos; Patsouris, Efstratios; Papalois, Apostolos.
Afiliação
  • Triantafillidis J; a Inflammatory Bowel Disease Unit, "IASO General" Hospital , Athens , Greece.
  • Vagianos C; b Inflammatory Bowel Disease Unit, "IASO General" Hospital , Holargos, Athens , Greece.
  • Agrogiannis G; c Department of Pathology , University of Athens Medical School , Athens , Greece.
  • Gikas A; d Health Center of Kalivia , Kalivia , Attiki , Greece.
  • Douvi G; a Inflammatory Bowel Disease Unit, "IASO General" Hospital , Athens , Greece.
  • Syrmos N; e Aristotle University of Thessaloniki School of Medicine , Thessaloniki , Greece.
  • Patsouris E; f University of Athens, School of Medicine , Athens , Greece.
  • Papalois A; g Experimental - Research Center ELPEN Pharmaceuticals , Athens , Greece.
J Invest Surg ; 30(1): 6-12, 2017 Feb.
Article em En | MEDLINE | ID: mdl-27537429

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Fator de Necrose Tumoral alfa / Adalimumab / Infliximab / Ferro / Anti-Inflamatórios Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Fator de Necrose Tumoral alfa / Adalimumab / Infliximab / Ferro / Anti-Inflamatórios Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article